{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:55:01Z","timestamp":1769187301763,"version":"3.49.0"},"reference-count":37,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0726","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T22:08:41Z","timestamp":1615586921000},"page":"713-727","source":"Crossref","is-referenced-by-count":20,"title":["Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI\/miR-335\/E2F3 ceRNA axis"],"prefix":"10.1507","volume":"68","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Guizhou Provincial People\u2019s Hospital, Guiyang City, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Guizhou Provincial People\u2019s Hospital, Guiyang City, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Guizhou Provincial People\u2019s Hospital, Guiyang City, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Hospital Of Guizhou Medical University, Guiyang City, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Guizhou Provincial People\u2019s Hospital, Guiyang City, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Hospital Of Guizhou Medical University, Guiyang City, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fagin JA, Wells SA Jr (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375: 1054\u20131067.","DOI":"10.1056\/NEJMra1501993"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Song YS, Park YJ (2019) Genomic characterization of differentiated thyroid carcinoma. Endocrinol Metab (Seoul) 34: 1\u201310.","DOI":"10.3803\/EnM.2019.34.1.1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, et al. (2019) Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci 16: 450\u2013460.","DOI":"10.7150\/ijms.29935"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Makazlieva T, Vaskova O, Majstorov V (2016) Etiopathogenesis of differentiated thyroid carcinomas. Open Access Maced J Med Sci 4: 517\u2013522.","DOI":"10.3889\/oamjms.2016.086"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Wu Q, Li P, Wu M, Liu Q (2019) Deregulation of circular RNAs in cancer from the perspectives of aberrant biogenesis, transport and removal. Front Genet 10: 16.","DOI":"10.3389\/fgene.2019.00016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Holdt LM, Kohlmaier A, Teupser D (2018) Molecular roles and function of circular RNAs in eukaryotic cells. Cell Mol Life Sci 75: 1071\u20131098.","DOI":"10.1007\/s00018-017-2688-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wang Y, Lu T, Wang Q, Liu J, Jiao W (2018) Circular RNAs: crucial regulators in the human body (Review). Oncol Rep 40: 3119\u20133135.","DOI":"10.3892\/or.2018.6733"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Peng N, Shi L, Zhang Q, Hu Y, Wang N, et al. (2017) Microarray profiling of circular RNAs in human papillary thyroid carcinoma. PLoS One 12: e0170287.","DOI":"10.1371\/journal.pone.0170287"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Lan X, Xu J, Chen C, Zheng C, Wang J, et al. (2018) The landscape of circular RNA expression profiles in papillary thyroid carcinoma based on RNA sequencing. Cell Physiol Biochem 47: 1122\u20131132.","DOI":"10.1159\/000490188"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Ren H, Liu Z, Liu S, Zhou X, Wang H, et al. (2018) Profile and clinical implication of circular RNAs in human papillary thyroid carcinoma. PeerJ 6: e5363.","DOI":"10.7717\/peerj.5363"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hashimoto I, Sakamaki K, Oue N, Kimura Y, Hiroshima Y, et al. (2019) Clinical significance of PRKCI gene expression in cancerous tissue in patients with gastric cancer. Anticancer Res 39: 5715\u20135720.","DOI":"10.21873\/anticanres.13771"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Liu F, Zhang J, Qin L, Yang Z, Xiong J, et al. (2018) Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation. Aging (Albany NY) 10: 3806\u20133820.","DOI":"10.18632\/aging.101674"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Liu Q, Pan LZ, Hu M, Ma JY (2020) Molecular network-based identification of circular RNA-associated ceRNA network in papillary thyroid cancer. Pathol Oncol Res 26: 1293\u20131299.","DOI":"10.1007\/s12253-019-00697-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Zhao ZJ, Shen J (2017) Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol 14: 514\u2013521.","DOI":"10.1080\/15476286.2015.1122162"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Parisi T, Yuan TL, Faust AM, Caron AM, Bronson R, et al. (2007) Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues. Mol Cell Biol 27: 2283\u20132293.","DOI":"10.1128\/MCB.01854-06"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Gao Y, Feng B, Lu L, Han S, Chu X, et al. (2017) MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers. Oncotarget 8: 60624\u201360639.","DOI":"10.18632\/oncotarget.17364"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kan Q, Su Y, Yang H (2017) MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2. Oncol Lett 14: 7622\u20137628.","DOI":"10.3892\/ol.2017.7126"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Luo L, Xia L, Zha B, Zuo C, Deng D, et al. (2018) miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells. Biomed Pharmacother 106: 983\u2013990.","DOI":"10.1016\/j.biopha.2018.07.046"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Teng H, Mao F, Liang J, Xue M, Wei W, et al. (2018) Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma. Theranostics 8: 4345\u20134358.","DOI":"10.7150\/thno.26862"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Navas-Carrillo D, Rodriguez JM, Montoro-Garcia S, Orenes-Pinero E (2017) High-resolution proteomics and metabolomics in thyroid cancer: deciphering novel biomarkers. Crit Rev Clin Lab Sci 54: 446\u2013457.","DOI":"10.1080\/10408363.2017.1394266"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Li Y, Chen M, Liu C, Xia Y, Xu B, et al. (2018) Metabolic changes associated with papillary thyroid carcinoma: a nuclear magnetic resonance-based metabolomics study. Int J Mol Med 41: 3006\u20133014.","DOI":"10.3892\/ijmm.2018.3494"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Guo D, Li F, Zhao X, Long B, Zhang S, et al. (2020) Circular RNA expression and association with the clinicopathological characteristics in papillary thyroid carcinoma. Oncol Rep 44: 519\u2013532.","DOI":"10.3892\/or.2020.7626"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Shi E, Ye J, Zhang R, Ye S, Zhang S, et al. (2020) A combination of circRNAs as a diagnostic tool for discrimination of papillary thyroid cancer. Onco Targets Ther 13: 4365\u20134372.","DOI":"10.2147\/OTT.S247796"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Wu G, Zhou W, Pan X, Sun Z, Sun Y, et al. (2020) Circular RNA profiling reveals exosomal circ_0006156 as a novel biomarker in papillary thyroid cancer. Mol Ther Nucleic Acids 19: 1134\u20131144.","DOI":"10.1016\/j.omtn.2019.12.025"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ma Y, Zhang D, Wu H, Li P, Zhao W, et al. (2020) Circular RNA PRKCI silencing represses esophageal cancer progression and elevates cell radiosensitivity through regulating the miR-186-5p\/PARP9 axis. Life Sci 259: 118168.","DOI":"10.1016\/j.lfs.2020.118168"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Zhang X, Yang H, Zhao L, Li G, Duan Y (2019) Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death Dis 10: 616.","DOI":"10.1038\/s41419-019-1863-z"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Qiu M, Xia W, Chen R, Wang S, Xu Y, et al. (2018) The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res 78: 2839\u20132851.","DOI":"10.1158\/0008-5472.CAN-17-2808"},{"key":"28","unstructured":"28 Zhang H, Ma XP, Li X, Deng FS (2019) Circular RNA circ_0067934 exhaustion expedites cell apoptosis and represses cell proliferation, migration and invasion in thyroid cancer <i>via<\/i> sponging miR-1304 and regulating CXCR1 expression. Eur Rev Med Pharmacol Sci 23: 10851\u201310866."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Zhang J, Liu Y, Liu Z, Wang XM, Yin DT, et al. (2013) Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Int J Med Sci 10: 585\u2013592.","DOI":"10.7150\/ijms.5794"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Li Q, Wang XJ, Jin JH (2019) SOX2-induced upregulation of lncRNA LINC01510 promotes papillary thyroid carcinoma progression by modulating miR-335\/SHH and activating Hedgehog pathway. Biochem Biophys Res Commun 520: 277\u2013283.","DOI":"10.1016\/j.bbrc.2019.09.138"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Schreiber C, Vormbrock K, Ziebold U (2012) Genes involved in the metastatic cascade of medullary thyroid tumours. Methods Mol Biol 878: 217\u2013228.","DOI":"10.1007\/978-1-61779-854-2_14"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Toki H, Inoue M, Minowa O, Motegi H, Saiki Y, et al. (2014) Novel retinoblastoma mutation abrogating the interaction to E2F2\/3, but not E2F1, led to selective suppression of thyroid tumors. Cancer Sci 105: 1360\u20131368.","DOI":"10.1111\/cas.12495"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 DeGregori J (2002) The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta 1602: 131\u2013150.","DOI":"10.1016\/S0304-419X(02)00051-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kumar B, Yadav A, Lang J, Teknos TN, Kumar P (2012) Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One 7: e37601.","DOI":"10.1371\/journal.pone.0037601"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, et al. (2011) Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer. Oncogene 30: 4038\u20134049.","DOI":"10.1038\/onc.2011.119"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Zhang Y, Chao T, Li R, Liu W, Chen Y, et al. (2009) MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med (Berl) 87: 43\u201351.","DOI":"10.1007\/s00109-008-0403-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Zang H, Li Y, Zhang X, Huang G (2020) Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression <i>via<\/i> miR-140-5p. Thorac Cancer 11: 1891\u20131903.","DOI":"10.1111\/1759-7714.13475"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/6\/68_EJ20-0726\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T04:35:14Z","timestamp":1625286914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/6\/68_EJ20-0726\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0726","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}